Winolap Ds 5 Ml

Description

Winolap DS 5 ml Eye Drops (Olopatadine Hydrochloride Ophthalmic Solution 0.2% w/v) is a premium, once-daily dual-action antihistamine and mast cell stabilizer manufactured by Sun Pharmaceutical Industries Ltd. Formulated for the rapid and long-lasting relief of ocular itching associated with allergic conjunctivitis, Winolap DS represents the “Double Strength” (DS) evolution of olopatadine therapy, offering 24-hour symptom control with a single application.

1. Manufacturer Profile: Sun Pharmaceutical Industries Ltd

Sun Pharma is a global pharmaceutical leader, recognized for its advanced research in ophthalmic delivery systems and its high-purity active pharmaceutical ingredients (APIs).

• Manufacturing Excellence: Produced in world-class facilities that comply with WHO-GMP and international regulatory requirements, ensuring that every 5 ml bottle maintains clinical potency and sterility.
• Quality Assurance: Sun Pharma’s Winolap DS is engineered to be bioequivalent to global innovator brands, providing patients with gold-standard allergy relief.

2. Composition & Ingredients

Each 1 ml of Winolap DS contains:

• Active Ingredient: Olopatadine Hydrochloride IP equivalent to Olopatadine 2 mg (0.2% w/v).
• Preservative: Benzalkonium Chloride 0.01% w/v.
• Vehicle: pH-balanced sterile aqueous solution (pH range 6.5–7.5) designed for maximum ocular comfort.

3. Mechanism of Action: How It Works

Winolap DS utilizes a sophisticated dual-action pharmacology to target the allergic response at its source.

A. Selective H1 Receptor Antagonism

Olopatadine is a highly selective histamine H1 receptor antagonist. Upon instillation, it rapidly blocks the binding of histamine to the receptors on the ocular surface, providing immediate relief from intense itching and redness within minutes.

B. Mast Cell Stabilization

Unlike simple antihistamines, Winolap DS also stabilizes mast cells. It prevents the degranulation of these cells, thereby inhibiting the release of pro-inflammatory mediators such as prostaglandins and leukotrienes. This prevents the “late-phase” allergic reaction, ensuring that the eyes remain clear and itch-free for up to 24 hours.

4. Therapeutic Indications

Winolap DS 5 ml is clinically indicated for:

• Seasonal Allergic Conjunctivitis: Managing symptoms triggered by pollen, grass, and outdoor allergens.
• Perennial Allergic Conjunctivitis: Long-term relief from indoor triggers like dust mites, pet dander, and mold.
• Giant Papillary Conjunctivitis (GPC): Often used as part of a management plan for contact lens-related irritation.

5. Clinical Comparison: Winolap DS vs. Standard Olopatadine

6. Dosing & Administration

Recommended Dosage

• Adults and Children (3+ Years): One drop in each affected eye **once daily**.

Application Guidelines

1. Wash hands thoroughly.
2. Tilt the head back and gently pull the lower eyelid down.
3. Instill one drop without touching the dropper tip to the eye or eyelashes.
4. Close the eye for 1 to 2 minutes. Apply gentle pressure to the inner corner (tear duct) to maximize ocular retention.
5. Wait at least 15 minutes before re-inserting contact lenses.

7. Precautions & Safety Warnings

• Contact Lenses: The preservative Benzalkonium Chloride can be absorbed by soft contact lenses. Always remove lenses before use.
• Age Limitation: Safety and efficacy have not been established in children under 3 years of age.
• Side Effects: Common localized effects include temporary blurred vision, dry eyes, or a mild “foreign body” sensation. These typically resolve within minutes.

8. Well-Researched FAQs

Q: Can I use Winolap DS more than once a day?

A: Winolap DS is specifically formulated for once-daily use. Using it more frequently does not typically increase efficacy and may increase the risk of local irritation. Consult your doctor if your symptoms persist.

Q: Is Winolap DS a steroid?

A: No. Winolap DS is an antihistamine and mast cell stabilizer. It does not carry the risks associated with long-term steroid use, such as cataracts or increased eye pressure.

Q: How long should I keep the bottle after opening?

A: Like most ophthalmic products, discard the bottle 30 days after first opening to ensure sterility.

9. Official Regulatory References

1. Sun Pharma Ophthalmic Index: Official Product Database
2. Clinical Monographs: Olopatadine Hydrochloride 0.2% in Once-Daily Dosing.

Medical Disclaimer: This content is AI-generated for educational purposes based on clinical pharmaceutical data. It is NOT medical advice. Always consult a licensed healthcare professional for diagnosis and treatment.